Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic-associated Steatohepatitis”

305 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 305 results

Testing effectiveness (Phase 2)Looking for participantsNCT07481734
What this trial is testing

Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)

Who this might be right for
Metabolic Associated Steatotic Liver DiseaseNonalcoholic SteatohepatitisHepatic Steatosis
Hudson Biotech 120
Testing effectiveness (Phase 2)Looking for participantsNCT06920043
What this trial is testing

Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated SteatohepatitisNon-alcoholic Fatty Liver Disease
GlaxoSmithKline 42
Testing effectiveness (Phase 2)Looking for participantsNCT07763015
What this trial is testing

Study of Resmetirom in Children and Adolescents With MASH

Who this might be right for
MASHMASH - Metabolic Dysfunction-Associated Steatohepatitis
Madrigal Pharmaceuticals, Inc. 61
Not applicableActive Not RecruitingNCT06983171
What this trial is testing

Semaglutide Effectiveness in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease in the Real World Practice

Who this might be right for
MAFLD
Center of target therapy 70
Not applicableNot Yet RecruitingNCT06795646
What this trial is testing

Clinical Classification of MAFLD Based Liver Biopsy

Who this might be right for
Metabolic Dysfunction Associated Steatotic Liver DiseaseMetabolic Dysfunction-associated Steatohepatitis (MASH)
Beijing Friendship Hospital 2,000
Large-scale testing (Phase 3)Looking for participantsNCT07221188
What this trial is testing

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

Who this might be right for
Non-alcoholic Fatty Liver Disease
GlaxoSmithKline 1,250
Large-scale testing (Phase 3)Looking for participantsNCT06419374
What this trial is testing

Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
89bio, Inc. 762
Post-approval studies (Phase 4)Study completedNCT05493761
What this trial is testing

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Aristotle University Of Thessaloniki 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07016633
What this trial is testing

To Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of IMM-H014 in Patients With MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Changchun Intellicrown Pharmaceutical Co. LTD 40
Not applicableLooking for participantsNCT06868992
What this trial is testing

Study of the Link Between MASH ( Metabolic Dysfunction-Associated Steatohepatitis) and MAMs (Mitochondria-Associated Membranes ) Alteration in Patients Undergoing Bariatric Surgery - MAMBA

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated SteatohepatitisSleeve Gastrectomy+1 more
Hospices Civils de Lyon 20
Not applicableUnknownNCT06180928
What this trial is testing

Short Term Outcome of Metabolic Associated Fatty Liver Disease (MAFLD) in Patients Undergoing Bariatric Surgery

Who this might be right for
Metabolic Associated Fatty Liver DiseaseBariatric Surgery Candidate
Assiut University 50
Early research (Phase 1)Looking for participantsNCT05945537
What this trial is testing

INI-822 in Healthy Volunteers and Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) or Presumed MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis
Inipharm Australia Pty Ltd 168
Not applicableUnknownNCT05421572
What this trial is testing

Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Who this might be right for
Fatty Liver Disease
Beijing Tsinghua Chang Gung Hospital 2,000
Not applicableStudy completedNCT06492369
What this trial is testing

MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients

Who this might be right for
Metabolic- Associated Fatty Liver Disease (MAFLD)
Tanta University 382
Early research (Phase 1)Not Yet RecruitingNCT07830758
What this trial is testing

Resmetirom in Patients With MASH and HFpEF

Who this might be right for
MASH - Metabolic Dysfunction-Associated SteatohepatitisHeart Failure With Preserved Ejection Fraction (HFPEF)
Madrigal Pharmaceuticals, Inc. 90
Not applicableNot Yet RecruitingNCT07430501
What this trial is testing

Using Digital Twin Technology and Clinical Decision Support Systems to Improve the Early Detection, Personalised Treatment, and Long-term Monitoring of Patients Across the Full Spectrum of Metabolic-associated Fatty Liver Disease (MAFLD).

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Hospital Universitari Vall d'Hebron Research Institute 7,720
Not applicableUnknownNCT06061640
What this trial is testing

The Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning Methods

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease
The First Affiliated Hospital of Zhejiang Chinese Medical University 500
Not applicableLooking for participantsNCT07313007
What this trial is testing

Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis (MASH)
Hospices Civils de Lyon 24
Early research (Phase 1)Looking for participantsNCT06575400
What this trial is testing

Test How Well Different Doses of BI 3804379 Are Tolerated by Healthy People and Patients With Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
HealthyMetabolic Dysfunction-associated Steatohepatitis
Boehringer Ingelheim 124
Not applicableStudy completedNCT04761900
What this trial is testing

MAFLD-simplified Definition as an Optimized Risk Stratification Tool for Predicting Metabolic Outcomes

Who this might be right for
Metabolic Associated Fatty Liver Disease
Ningbo No. 1 Hospital 3,372
Next Page